Cladribine cleared for review

Mavenclad is an oral treatment for relapsing MS and active secondary progressive MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Cladribine cleared for review

Post by MSUK » Mon Jul 18, 2016 3:04 am

Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) of the investigational product Cladribine for the treatment of relapsing-remitting multiple sclerosis (MS)...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/

User avatar
frodo
Family Elder
Posts: 1328
Joined: Wed Dec 02, 2009 3:00 pm
Contact:

Re: Cladribine cleared for review

Post by frodo » Fri Aug 19, 2016 7:38 am

MSUK wrote:Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) of the investigational product Cladribine for the treatment of relapsing-remitting multiple sclerosis (MS)...Read more - http://www.ms-uk.org/MSnews
Thanks. Good news for everybody following the pipeline. Some people will benefit directly and the rest will benefit from the information collected.

Post Reply
  • Similar Topics
    Replies
    Views
    Last post